Competing interests ML, FL, CR-D, AL, and RP are employees of, and are shareholders in, Sanofi
Where covered, Wegovy is placed on a specialty tier and requires prior authorization: BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea), plus documented participation in a lifestyle or weight-management program
Thats why we created THE EYE LAB our natural laboratory where the power of botanicals meets scientific precision
Both are essential to cellular health, yet they operate through very different biological mechanisms
The difference demonstrates that medication acts as a powerful tool to lower hunger and support adherence to healthier choices, rather than a standalone cure for obesity